TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
3 clinical trials · Sponsor
◉ Watch TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
| Record | Firm | Date |
|---|---|---|
| BBO-11818 in Adult Subjects With KRAS Mutant Cancer (NCT06917079) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2025-03-31 |
| Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors (NCT06625775) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2024-10-29 |
| Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer (NCT06343402) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2024-05-22 |
Track TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) automatically
Every clearance here is in the API, with alerts when new ones post.